Key result
Structured protocol for hybrid stage 1 palliation is linked to ~18-point higher 1-year survival.
Why the study?
Does a structured management protocol and contemporary institutional experience (Era 2 vs Era 1) improve one-year survival in infants undergoing hybrid stage 1 palliation for hypoplastic left heart syndrome and similar single ventricle lesions?
Cohort (n=281)
No
Does a structured management protocol and contemporary institutional experience (Era 2 vs Era 1) improve one-year survival in infants undergoing hybrid stage 1 palliation for hypoplastic left heart syndrome and similar single ventricle lesions?
When used as a standard strategy with a structured management protocol, contemporary hybrid stage 1 palliation for single ventricle lesions achieves an 83% one-year survival rate, significantly improved over earlier institutional eras.
Answers are grounded in this paper and cite their sources.
May inform hybrid palliation protocols for HLHS; leaves open need for prospective trials versus Norwood.
The hybrid stage 1 palliation (HS1P), an alternative to the Norwood procedure for hypoplastic left heart syndrome (HLHS), is often reserved for high-risk patients. We aimed to evaluate the survival of HS1P through one year when used as standard palliation strategy for HLHS and similar lesions and to assess changes in survival over time. Retrospective cohort study of all infants who underwent HS1P for single ventricle palliation. A structured protocol for patient management was developed between 2009 and 2017, with all components implemented by June 2017. Patients were stratified into two cohorts based on timing of HS1P: Era 1 (January 2002 - May 2017), and Era 2 (June 2017 - December 2024). The primary outcome was survival through one year. A total of 281 infants underwent HS1P, 221 in Era 1 and 60 in Era 2. Median age at HS1P was 6 days for both groups. Balloon atrial septostomy at the time of HS1P was significantly more common in Era 2 (43% vs 4% in Era 1), as was use of smaller bands (p <0.001 for both). One-year survival was significantly higher in Era 2 compared to Era 1 (83% vs 65%, p=0.01), and this benefit persisted in multivariable analysis. In this study of HS1P used as standard palliation, contemporary survival was excellent with significant improvements in outcomes in more recent years. Further study is needed to understand longer-term outcomes and the interplay of patient risk factors, to help guide best practices.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2026) conducted a cohort in Hypoplastic left heart syndrome (HLHS) and similar single ventricle lesions (n=281). Era 2 (June 2017 - December 2024) hybrid stage 1 palliation with full structured management protocol vs. Era 1 (January 2002 - May 2017) hybrid stage 1 palliation prior to full protocol implementation was evaluated on Survival through one year (p=0.01). Hybrid stage 1 palliation in Era 2 (after structured protocol implementation) had higher 1-year survival compared to Era 1.
Synapse has enriched 10 related papers. Consider them for comparative context: